Clinical Impacts of Heterogeneous Interferon Responses to Viral Infection by Asthmatic Airway Epithelium

异质干扰素对哮喘气道上皮病毒感染反应的临床影响

基本信息

  • 批准号:
    10265757
  • 负责人:
  • 金额:
    $ 6.72万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-07-01 至 2022-01-31
  • 项目状态:
    已结题

项目摘要

Project Summary Asthma exacerbations among U.S children result in 640,000 emergency department visits and 14 million missed school days annually. Viral infections trigger the majority of exacerbations in children, of which human rhinoviruses (HRV) are the most common. The airway epithelium plays central roles in regulating inflammation, airway remodeling responses, and innate immune responses to infection. The most striking response of airway epithelial cells (AECs) to viral infection is expression of type I and III interferons (IFN I/III) and IFN stimulated genes (ISG). Some have reported deficient IFN I/III responses to viral infection by asthmatic AECs and postulated that deficient epithelial IFN responses to viruses predispose to exacerbations, whereas others have not observed differences in AEC IFN responses to viruses between asthmatic and healthy AECs. In our unique cohort of well characterized asthmatic and healthy children, from whom we obtain bronchial and nasal AECs and conduct mechanistic experiments using air-liquid-interface organotypic culture models, we have observed significant heterogeneity in IFN I/III responses to HRV and RSV infection. For example, among our asthmatic AEC donors we have noted associations between high type I/III IFN responses and lower donor lung function, as well as distinct subgroups of exacerbation prone asthmatics with deficient IFN I/III responses to HRV. Heterogeneity in AEC IFN I/III responses to viral infections may be explained by polymorphisms in genes coding for viral sensors and/or key steps in signal transduction pathways upstream of IFN I and III. The overall goal my research program is to understand how airway epithelial responses influence viral-triggered exacerbations and airway remodeling mechanisms in asthmatic children. In the first aim, using primary cells from children with asthma we will test our hypothesis that polymorphisms in genes coding for viral sensors, and/or key steps in signal transduction pathways upstream of IFN responses, contribute to heterogeneity in IFN I/III responses to HRV infection by AECs from asthmatic children. In the second aim, we will prospectively follow a cohort of asthmatic children to test our hypothesis that deficient AEC IFN I/III responses to HRV are associated with a greater incidence of viral-triggered exacerbations in AEC donors. In the final aim, we will test our hypothesis that excessively high IFN I/III responses by asthmatic AECs to HRV are associated with lung function decline among AEC donors, and we will interrogate potential mechanisms whereby excessively high IFN I/III responses may promote proliferation and activation of lung stromal cells. The studies conducted in my research program and unique resource of primary airway epithelial cells from clinically well characterized asthmatic children provide an exceptional training environment for young investigators dedicated to a career in mechanistic patient-oriented research to learn translational research techniques to investigate the role of the airway epithelium in pediatric lung diseases and viral infection.
项目摘要 美国儿童中的哮喘恶化导致640,000个急诊室就诊和1400万 每年错过上学的日子。病毒感染引发了儿童的大部分加重,其中人类 鼻病毒(HRV)是最常见的。气道上皮在调节中起着核心作用 炎症,气道重塑反应以及对感染的先天免疫反应。最引人注目的 气道上皮细胞(AEC)对病毒感染的反应是I型和III干扰素的表达(IFN I/III) 和IFN刺激基因(ISG)。有些人报告说,IFN I/III对病毒感染的反应不足 哮喘AEC,并假设缺乏上皮的IFN对病毒的反应易于加剧, 而其他人则没有观察到哮喘和 健康的AEC。在我们独特的哮喘和健康的孩子中,我们从中获得了 支气管和鼻腔AEC并使用空气 - 界面器官型培养物进行机械实验 模型,我们观察到IFN I/III对HRV和RSV感染的反应中的显着异质性。为了 例如,在我们哮喘的AEC供体中,我们注意到高I/III IFN响应之间的关联 和较低 IFN I/III对HRV的响应。 AEC IFN I/III对病毒感染的异质性可能由 编码病毒传感器和/或信号转导途径中的关键步骤的基因中的多态性 IFN I和III。我的研究计划的总体目标是了解气道上皮反应 哮喘儿童影响病毒触发的加重和气道重塑机制。在 首先,使用哮喘儿童的主要细胞,我们将测试我们的假设,即多态性 编码病毒传感器的基因和/或IFN响应上游信号转导途径的关键步骤, 在IFN I/III对HRV感染的反应中有助于哮喘儿童对HRV感染的异质性。在 第二个目的,我们将前瞻性地跟随一群哮喘儿童来检验我们的假设 AEC IFN I/III对HRV的响应与AEC病毒触发加重的发生率更大有关 捐助者。在最终目标中,我们将测试我们的假设,即哮喘的IFN I/III反应过高 到HRV的AEC与AEC捐助者之间的肺功能下降有关,我们将询问潜力 IFN I/III反应过高的机制可能会促进肺的增殖和激活 基质细胞。在我的研究计划中进行的研究和主要气道上皮的独特资源 临床表征哮喘儿童的细胞为年轻人提供了出色的训练环境 研究人员致力于机械性的以患者为导向的研究,以学习翻译研究 研究气道上皮在小儿肺部疾病和病毒感染中的作用的技术。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JASON S DEBLEY其他文献

JASON S DEBLEY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JASON S DEBLEY', 18)}}的其他基金

Dysregulated asthmatic epithelial interferon responses to viruses drive exacerbation, T2 inflammation, and airway remodeling
哮喘上皮干扰素对病毒的反应失调会导致病情加重、T2 炎症和气道重塑
  • 批准号:
    10558633
  • 财政年份:
    2022
  • 资助金额:
    $ 6.72万
  • 项目类别:
Dysregulated asthmatic epithelial interferon responses to viruses drive exacerbation, T2 inflammation, and airway remodeling
哮喘上皮干扰素对病毒的反应失调会导致病情加重、T2 炎症和气道重塑
  • 批准号:
    10446799
  • 财政年份:
    2022
  • 资助金额:
    $ 6.72万
  • 项目类别:
Clinical Impacts of Heterogeneous Interferon Responses to Viral Infection by Asthmatic Airway Epithelium
异质干扰素对哮喘气道上皮病毒感染反应的临床影响
  • 批准号:
    10552683
  • 财政年份:
    2020
  • 资助金额:
    $ 6.72万
  • 项目类别:
Clinical Impacts of Heterogeneous Interferon Responses to Viral Infection by Asthmatic Airway Epithelium
异质干扰素对哮喘气道上皮病毒感染反应的临床影响
  • 批准号:
    10330561
  • 财政年份:
    2020
  • 资助金额:
    $ 6.72万
  • 项目类别:
Dysregulated Airway Epithelial Signaling as a Driver of Airway Remodeling in Asthmatic Children
气道上皮信号失调是哮喘儿童气道重塑的驱动因素
  • 批准号:
    9130413
  • 财政年份:
    2015
  • 资助金额:
    $ 6.72万
  • 项目类别:
NONINVASIVE MEASURES OF AIRWAY INFLAMMAITON AND AIRFLOW OBSTRUCTION IN WHEEZY
喘息时气道炎症和气流阻塞的非侵入性治疗
  • 批准号:
    7603558
  • 财政年份:
    2007
  • 资助金额:
    $ 6.72万
  • 项目类别:
AIRFLOW OBSTRUCTION AND BIOMARKERS OF AIRWAY DURING AND FOLLOWING OF ASTHMA
哮喘期间和之后的气流阻塞和气道生物标志物
  • 批准号:
    7603551
  • 财政年份:
    2007
  • 资助金额:
    $ 6.72万
  • 项目类别:
AIRFLOW OBSTRUCTION AND BIOMARKERS OF AIRWAY INFLAMATION
气流阻塞和气道炎症的生物标志物
  • 批准号:
    7379438
  • 财政年份:
    2006
  • 资助金额:
    $ 6.72万
  • 项目类别:
Noninvasive Measures in Wheezy Infants and Toddlers
喘息婴幼儿的无创治疗
  • 批准号:
    6956540
  • 财政年份:
    2005
  • 资助金额:
    $ 6.72万
  • 项目类别:
Noninvasive Measures in Wheezy Infants and Toddlers
喘息婴幼儿的无创治疗
  • 批准号:
    7103668
  • 财政年份:
    2005
  • 资助金额:
    $ 6.72万
  • 项目类别:

相似国自然基金

室内空气湿度对儿童过敏性哮喘发病的影响及其机理
  • 批准号:
    51908079
  • 批准年份:
    2019
  • 资助金额:
    21.0 万元
  • 项目类别:
    青年科学基金项目
基于时间序列的空气质量与生活污水中哮喘药物残留的关系
  • 批准号:
    41877466
  • 批准年份:
    2018
  • 资助金额:
    61.0 万元
  • 项目类别:
    面上项目
室内空气中PM2.5及其赋存典型内分泌干扰物的污染与暴露
  • 批准号:
    21477072
  • 批准年份:
    2014
  • 资助金额:
    85.0 万元
  • 项目类别:
    面上项目
CC16作为空气污染暴露、哮喘易感基因与儿童哮喘效应评价的生物标记物可行性研究
  • 批准号:
    81302405
  • 批准年份:
    2013
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
我国北方城市空气污染中PM2.5对支气管哮喘的影响及其机制的研究
  • 批准号:
    81302403
  • 批准年份:
    2013
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Trajectories of Regional Cardiopulmonary Structure and Function in A Longitudinal Cohort of Extremely Preterm Infants
极早产儿纵向队列的区域心肺结构和功能轨迹
  • 批准号:
    10656624
  • 财政年份:
    2023
  • 资助金额:
    $ 6.72万
  • 项目类别:
Predicting Exacerbations of Asthma in Real-World Patients with Low Medical Utilization (PEARL)
预测现实世界中医疗利用率低的患者的哮喘恶化 (PEARL)
  • 批准号:
    10585179
  • 财政年份:
    2023
  • 资助金额:
    $ 6.72万
  • 项目类别:
DLL4 in the Developing Lung and Bronchopulmonary Dysplasia (BPD)
DLL4 在发育中的肺和支气管肺发育不良 (BPD) 中的作用
  • 批准号:
    10584811
  • 财政年份:
    2023
  • 资助金额:
    $ 6.72万
  • 项目类别:
Macrophages in steroid resistant asthma
类固醇抵抗性哮喘中的巨噬细胞
  • 批准号:
    10381135
  • 财政年份:
    2022
  • 资助金额:
    $ 6.72万
  • 项目类别:
Macrophages in steroid resistant asthma
类固醇抵抗性哮喘中的巨噬细胞
  • 批准号:
    10705009
  • 财政年份:
    2022
  • 资助金额:
    $ 6.72万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了